Las Vegas City Attorney Rebecca Wolfson has raised more than $340,000 in a race for Municipal Court, out fundraising all other judicial candidates in the upcoming primary elections.
Politics and Government
Speakers at a Board of Regents meeting expressed disappointment in a lack of response from the board and UNLV leadership on a recent commencement speech.
The lawsuit was being brought with 30 state and district attorneys general and seeks to break up the monopoly they say is squeezing out smaller promoters and hurting artists.
With the campaign season in full swing, 10 hopefuls pitched their vision for the city’s future to at the “Meet the Candidates” forum in the west valley.
Clark County will likely challenge a district court judge’s decision in the ongoing litigation with Gypsum Resources to the state Supreme Court.
The Centers for Disease Control recommended the shots that target the newest omicron strains of COVID-19, including one for people 12 and older.
Worldwide used vaccine, Novavax now available for adults in Clark County.
The Interior Department says Deb Haaland is isolating in Nevada where she took part in a roundtable discussion Tuesday about clean energy production on public lands.
In an extraordinary move, the Food and Drug Administration had urged Pfizer and its partner BioNTech to apply earlier than the companies had planned.
Clark County showed more progress in curbing the current COVID-19 surge, but still remained a ways away from meeting the criteria needed to exit the governor’s mask mandate.
Clark County on Wednesday reported 548 new coronavirus cases and 12 deaths as its major metrics for the disease showed mixed signals.
Nevada State Higher Education system officials said they hadn’t yet compiled records from individual colleges and universities and don’t know how many complied with the mandate.
Data from the Centers for Disease Control and Prevention moves the county closer to exiting the state’s mask mandate for indoor public settings.
U.S. regulators are delaying their decision on Moderna’s COVID-19 vaccine for 12- to 17-year-olds while they study the rare risk of heart inflammation, the company said Sunday.
The two-week moving average of new COVID-19 cases dropped more than 10 percent, adding to evidence that the coronavirus is at least temporarily in retreat.